Plasma 3,4-dihydroxyphenylethyleneglycol and 3-methoxy-4-hydroxyphenylethyleneglycol as indicators of central noradrenergic activity. A comparative study on control subjects and depressed patients.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 3075724)

Published in Neuropsychobiology on January 01, 1988

Authors

J M Azorin1, F Karege, M Valli, D Pringuey, P Joanny, R Tissot

Author Affiliations

1: Department of Psychiatry, Timone Hospital, Aix-Marseille University, France.

Articles by these authors

[Disturbances of catecholamine metabolism (with special reference to dopamine) in the Parkinsonian syndrome]. Presse Med (1969) 1.77

Qualitative analysis of unilateral spatial neglect in relation to laterality of cerebral lesions. J Neurol Neurosurg Psychiatry (1972) 1.57

Growth hormone treatment in osteogenesis imperfecta with quantitative defect of type I collagen synthesis. J Pediatr (1996) 1.56

[Treatment of clozapine-induced granulocytopenia with lithium (two observations)]. Encephale (2005) 1.45

Circadian rhythms in depression and recovery: evidence for blunted amplitude as the main chronobiological abnormality. Psychiatry Res (1989) 1.44

Disability, mortality, and incidence of cancer among Geneva painters and electricians: a historical prospective study. Br J Ind Med (1989) 1.33

Guidelines for the dosage of neuroleptics. I: Chlorpromazine equivalents of orally administered neuroleptics. Int Clin Psychopharmacol (1989) 1.29

The safety and tolerability of zolpidem--an update. J Psychopharmacol (1999) 1.28

Pick's disease. Histological and clinical correlations. Eur Neurol (1974) 1.27

Hyperbaric oxygen: effects on metabolism and ionic movement in cerebral cortex slices. Science (1970) 1.21

Response to psychotherapy in borderline personality disorder and methylation status of the BDNF gene. Transl Psychiatry (2013) 1.17

Metabolic fate of l-[14C] DOPA in cerebrospinal fluid and blood plasma of humans. Brain Res (1967) 1.14

[Oculo-facio-cervical dystonia (Steele-Richardson-Olszewski progressive supranuclear paralysis). Ophthalmic pseudo-paralysis, visuo-spatial disorders, pseudo-dementia and neuronal changes]. Rev Neurol (Paris) (1970) 1.10

Unilateral microfibrillar abnormalities in a case of asymmetric Marfan syndrome. Am J Hum Genet (1990) 1.08

The metabolism of L-3-O-methyldopa, a precursor of dopa in man. Clin Pharmacol Ther (1971) 1.06

Interphysician variability in defining the planning target volume in the irradiation of prostate and seminal vesicles. Radiother Oncol (1998) 1.05

Nuclear retention of COL1A1 messenger RNA identifies null alleles causing mild osteogenesis imperfecta. J Clin Invest (1996) 1.04

A pedigree possible evidence for the metabolic interference hypothesis. Am J Hum Genet (1981) 1.03

Uptake of monosaccharides by guinea-pig cerebral-cortex slices. Biochem J (1969) 1.02

Activity of levofloxacin and ciprofloxacin against urinary pathogens. J Antimicrob Chemother (2001) 1.00

[Substitutive therapy in Parkinson's syndromes. L-dopa plus peripheral decarboxylase inhibitor or 3-0-methyl dopa?]. Presse Med (1971) 1.00

Osteogenesis imperfecta: clinical, biochemical and molecular findings. Clin Genet (2006) 0.99

[Treatment of Parkinsonism with oral L-DOPA combined with a decarboxylase inhibitor (Ro IV 46.02)]. Presse Med (1969) 0.98

Treatment of benign prostatic hyperplasia with 5-alpha-reductase inhibitor: morphological changes in patients who fail to respond. J Clin Pathol (1996) 0.94

[Generalized Alzheimer's neurofibrillary lesions without senile plaques. (Presentation of one anatomo-clinical case)]. Schweiz Arch Neurol Neurochir Psychiatr (1967) 0.93

Drug-induced changes of extracerebral dopa metabolism in man. Arch Neurol (1969) 0.93

Accumulation of dopamine in the parenchyma after decarboxylase inhibition in the capillaries of brain. Experientia (1968) 0.92

[Are catatonia and neuroleptic malignant syndrome related conditions?]. Encephale (2009) 0.92

Toxicity of some essential plant oils. Clinical and experimental study. Clin Toxicol (1981) 0.91

Human cells unable to express decoron produced disorganized extracellular matrix lacking "shape modules" (interfibrillar proteoglycan bridges). Exp Cell Res (1998) 0.91

Behavioral and psychological symptoms in Alzheimer's disease. Relation between apathy and regional cerebral perfusion. Dement Geriatr Cogn Disord (2000) 0.90

beta 1,3-Galactosyltransferase beta 3Gal-T5 acts on the GlcNAcbeta 1-->3Galbeta 1-->4GlcNAcbeta 1-->R sugar chains of carcinoembryonic antigen and other N-linked glycoproteins and is down-regulated in colon adenocarcinomas. J Biol Chem (2000) 0.89

gamma-Aminobutyric acid (GABA) receptor stimulation. III. Effect of progabide (SL 76002) on norepinephrine, dopamine and 5-hydroxytryptamine turnover in rat brain areas. J Pharmacol Exp Ther (1982) 0.88

Achilles and patellar tendinopathies in athletes: pathogenesis and surgical treatment. Bull Hosp Jt Dis (1996) 0.88

Possible role of overglycosylation in the type I collagen triple helical domain in the molecular pathogenesis of osteogenesis imperfecta. Am J Med Genet (1993) 0.88

The common pathophysiology of monaminergic psychoses: a new hypothesis. Neuropsychobiology (1975) 0.87

On the origin of homovanillic acid in the cerebrospinal fluid. Experientia (1966) 0.87

[Treatment of parkinsonism with L-Dopa associated with decarboxylase inhibitors. II]. Rev Neurol (Paris) (1970) 0.86

Inherited congenital adrenal hyperplasia in the rabbit: absent cholesterol side-chain cleavage cytochrome P450 gene expression. Endocrinology (1992) 0.86

EEG sleep studies of insomniacs under flunitrazepam treatment. Int Pharmacopsychiatry (1975) 0.86

Metabolic and hemodynamic changes during recovery and tracheal extubation in neurosurgical patients: immediate versus delayed recovery. Anesth Analg (1999) 0.86

The decrease of erythrocyte catechol-O-methyltransferase activity in depressed patients and its diagnostic significance. Acta Psychiatr Scand (1987) 0.86

Mild dominant osteogenesis imperfecta with intrafamilial variability: the cause is a serine for glycine alpha 1(I) 901 substitution in a type-I collagen gene. Hum Genet (1992) 0.85

Osteogenesis imperfecta: morphological, histochemical and biochemical aspects. Modifications induced by (+)-catechin. Connect Tissue Res (1977) 0.85

Uptake of some amino acids by rat brain slices: effect of various substrates. Experientia (1968) 0.85

[Recent aspects of the study of sleep in humans]. Schweiz Arch Neurol Neurochir Psychiatr (1965) 0.85

Pelvic and para-aortic lymph nodal positivity in the ovarian carcinoma: its prognostic significance. Eur J Gynaecol Oncol (1988) 0.85

Quantitative study of ductal breast cancer progression. A progression index (P.I.) for premalignant lesions and in situ carcinoma. Pathol Res Pract (1996) 0.84

Paternal mosaicism for a COL1A1 dominant mutation (alpha 1 Ser-415) causes recurrent osteogenesis imperfecta. Hum Mutat (1993) 0.83

Effect of the hour of administration on the pharmacokinetics of lidocaine in the rat. Eur J Drug Metab Pharmacokinet (1984) 0.82

Delta sleep-inducing peptide in the rat brain: an immunohistological microscopic study. Neuropsychobiology (1983) 0.82

Antinociceptive action of sodium valproate in the mouse. Gen Pharmacol (1983) 0.82

Relapse of low-grade gastric MALT lymphoma after Helicobacter pylori eradication: true relapse or persistence? Long-term post-treatment follow-up of a multicenter trial in the north-east of Italy and evaluation of the diagnostic protocol's adequacy. Recent Results Cancer Res (2000) 0.82

Study of factors affecting the determination of total plasma 7-fluorobenzo-2-oxa-1,3-diazole-4-sulfonate (SBD)-thiol derivatives by liquid chromatography. J Chromatogr B Biomed Sci Appl (1998) 0.82

Differential expression of beta1,3galactosyltransferases in human colon cells derived from adenocarcinomas or normal mucosa. FEBS Lett (1999) 0.81

[Effects of hypo- and hyperthermia on respiratory intensity, rates of intracellular penetration and glucose oxidation, and on the level of energy rich phosphorylated compound of the isolated cerebral tissue of mammals in vitro]. C R Seances Soc Biol Fil (1966) 0.81

Unusual neurotoxic envenomations by Vipera aspis aspis snakes in France. Hum Exp Toxicol (2002) 0.81

Differential effects of acute and chronic administration of haloperidol on substance P and enkephalins in diverse rat brain areas. Neuropsychobiology (1986) 0.81

[Familial incidence of Alzheimer's cortical neurofibrillar changes]. Psychiatr Neurol (Basel) (1965) 0.81

[The capillary enzyme barrier for DOPA at the level of some brain stem nuclei in the rat]. Experientia (1970) 0.81

Brain capillaries as a source of homovanillic acid in cerebrospinal fluid. Brain Res (1971) 0.81

[Plasma MHPG, peripheral noradrenergic marker and hormonal plasma levels of cortisol-T3-T4-TSH in depressive syndromes]. Encephale (1991) 0.81

Formation of monoamines from various amino acids in the brain after inhibition of extracerebral decarboxylase. Biochem Pharmacol (1971) 0.81

[Propranolol and arterial hypertension: study with frequent daily checking of blood pressure and serum levels after 1 week of treatment]. Acta Cardiol (1975) 0.80

Guidelines for the dosage of neuroleptics. II: Changing from daily oral to long acting injectable neuroleptics. Int Clin Psychopharmacol (1989) 0.80

[Plasma levels and membrane transports in red blood cell of tyrosine and tryptophane in depression. Evaluation at baseline and recovery]. Encephale (1991) 0.80

Lithium kinetics during hemodialysis in a patient with lithium poisoning. Am J Psychiatry (1981) 0.80

Radical vulvectomy and inguinal lymphadenectomy versus inguino-pelvic lymphadenectomy combined with radical vulvectomy and the role of radiotherapy. Eur J Gynaecol Oncol (1988) 0.80

[Urinary excretion of 5-hydroxyindoleacetic acid, vanillomandelic acid and xanthurenic acid in 18 Mongoloids]. Pathol Biol (1966) 0.80

Cytometric evidence that cervical intraepithelial neoplasia I and II are dysplasias rather than true neoplasias. An image analysis study of factors involved in the progression of cervical lesions. Anal Quant Cytol Histol (1992) 0.80

[Automatic analysis of polygraphic sleep recordings]. Electroencephalogr Clin Neurophysiol (1971) 0.80

Sodium valproate: kinetic profile and effects on GABA levels in various brain areas of the rat. Prog Neuropsychopharmacol Biol Psychiatry (1982) 0.80

Comparative investigation of inhibitors of extracerebral dopa decarboxylase in man and rats. J Pharm Pharmacol (1972) 0.80

[Comparative study of sodium valproate and ketoprofen in the treatment of postoperative pain]. Ann Fr Anesth Reanim (1988) 0.80

[Doping in sports. Cases reported to the Poison Control Center of Marseille from 1992 to 2000]. Presse Med (2001) 0.79

[Degeneration of an anterior segment of the corpus callosum in a chronic alcoholic patient]. Rev Otoneuroophtalmol (1971) 0.79

Principles of automatic analysis of sleep records with a hybrid system. Comput Biomed Res (1973) 0.79

Phenotypic comparison of an osteogenesis imperfecta type IV proband with a de novo alpha2(I) Gly922 --> Ser substitution in type I collagen and an unrelated patient with an identical mutation. Biochem Mol Med (1997) 0.79

Antidepressant effect of 5-methoxypsoralen: The melatonin synchronizer hypothesis. Eur Psychiatry (1995) 0.79

Glycosaminoglycan alterations in osteogenesis imperfecta. Ital J Biochem (1981) 0.79

The uptake and efflux of glycine from rat cerebral-cortex slices. Biochem J (1971) 0.79

Electronic patient record systems and the general practitioner: an evaluation study. J Telemed Telecare (2005) 0.79

[Progabide treatment of a case of the syndrome of painful legs and moving toes]. Rev Neurol (Paris) (1985) 0.79

[Study of H and T reflexes in Parkinsonism. Modification of these reflexes by L-Dopa]. Encephale (1971) 0.79

Mechanical ventilation increases substance P concentration in the vagus, sympathetic, and phrenic nerves. Am J Respir Crit Care Med (1996) 0.79

Structural and optical properties of silicon oxynitride on silicon planar waveguides. Appl Opt (1990) 0.78

Treatment-resistant schizophrenia: the importance of early detection and treatment. Introduction. J Clin Psychopharmacol (1998) 0.78

The uptake and efflux of L-phenylalanine and L-tyrosine from rat brain cerebral cortex slices. Biochem J (1973) 0.78

[Absence of effects of sodium valproate on the estrous cycle of the rat]. C R Seances Soc Biol Fil (1982) 0.78

Trimipramine: acute and lasting effects on sleep in healthy and major depressive subjects. J Affect Disord (1992) 0.78

Effect of one hyperbaric oxygen-induced convulsion on cortical polyamine content in two strains of mice. Neurosci Lett (1993) 0.78

Continuous monitoring of an endocardial index of myocardial contractility during head-up tilt test. Am Heart J (2000) 0.78

Effects of subinhibitory concentrations of ibuprofen isobuthanolammonium on virulence factors of uropathogenic Escherichia coli. J Chemother (2002) 0.78

Quantitative study of ductal breast cancer progression. Morphometric evaluation of phenotypical changes occurring in benign and preinvasive epithelial lesions. Pathol Res Pract (1994) 0.78

Involvement of sulfhydryl groups in the transport of L-tyrosine and L-tryptophan across the human red cell membrane in vitro. Neuropsychobiology (1989) 0.78

Inositol monophosphate esterase inhibition by lithium in normal human studies using neuroendocrine tests. Part I. PRL and TSH responses to TRH. Prog Neuropsychopharmacol Biol Psychiatry (1990) 0.78

Osteoblasts extracellular matrix induces vessel like structures through glycosylated collagen I. Exp Cell Res (2009) 0.78

Passage into the rat brain of dopa and dopamine injected into the lateral ventricle. Br J Pharmacol (1971) 0.78

Distribution of sodium valproate and GABA metabolism in CNS of the rat. Biopharm Drug Dispos (1985) 0.78